Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo.
Saved in:
| Title: | Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo. |
|---|---|
| Authors: | Mao J; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Chen Y; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zong Q; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Liu C; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Xie J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wang Y; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Fisher D; Department of Medical Biosciences, Faculty of Natural Sciences, University of The Western Cape, Cape Town, South Africa., Hien NTT; Hai Phong University of Medicine and Pharmacy, Haiphong, Vietnam., Pronyuk K; Department of Infectious Diseases, O.Bogomolets National Medical University, Kyiv, Ukraine., Musabaev E; Research Institute of Virology, Ministry of Health, Tashkent, Uzbekistan., Li Y; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhao L; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Dang Y; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. |
| Source: | Frontiers in immunology [Front Immunol] 2024 May 13; Vol. 15, pp. 1364161. Date of Electronic Publication: 2024 May 13 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38803504 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mao+J%22">Mao J</searchLink>; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Zong+Q%22">Zong Q</searchLink>; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Liu+C%22">Liu C</searchLink>; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Xie+J%22">Xie J</searchLink>; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Fisher+D%22">Fisher D</searchLink>; Department of Medical Biosciences, Faculty of Natural Sciences, University of The Western Cape, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Hien+NTT%22">Hien NTT</searchLink>; Hai Phong University of Medicine and Pharmacy, Haiphong, Vietnam.<br /><searchLink fieldCode="AU" term="%22Pronyuk+K%22">Pronyuk K</searchLink>; Department of Infectious Diseases, O.Bogomolets National Medical University, Kyiv, Ukraine.<br /><searchLink fieldCode="AU" term="%22Musabaev+E%22">Musabaev E</searchLink>; Research Institute of Virology, Ministry of Health, Tashkent, Uzbekistan.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Zhao+L%22">Zhao L</searchLink>; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Dang+Y%22">Dang Y</searchLink>; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 May 13; Vol. 15, pp. 1364161. <i>Date of Electronic Publication: </i>2024 May 13 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38803504 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1364161 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1364161 Titles: – TitleFull: Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mao J – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Zong Q – PersonEntity: Name: NameFull: Liu C – PersonEntity: Name: NameFull: Xie J – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Fisher D – PersonEntity: Name: NameFull: Hien NTT – PersonEntity: Name: NameFull: Pronyuk K – PersonEntity: Name: NameFull: Musabaev E – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Zhao L – PersonEntity: Name: NameFull: Dang Y IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 05 Text: 2024 May 13 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
